These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10374713)

  • 1. Relationship between myocardial cation content and injury in reperfused rat hearts treated with cation channel blockers.
    Tanonaka K; Kajiwara H; Kameda H; Takasaki A; Takeo S
    Eur J Pharmacol; 1999 May; 372(1):37-48. PubMed ID: 10374713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
    Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
    Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of KB-R7943, a novel Na+/Ca2+ exchange inhibitor, on myocardial ischemia/reperfusion injury].
    Nakamura A; Harada K; Sugimoto H; Nakajima F; Nishimura N
    Nihon Yakurigaku Zasshi; 1998 Feb; 111(2):105-15. PubMed ID: 9558649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
    Du Toit EF; Muller CA; McCarthy J; Opie LH
    J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated, perfused hearts.
    Takeo S; Tanonaka K; Hayashi M; Yamamoto K; Liu JX; Kamiyama T; Yamaguchi N; Miura A; Natsukawa T
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1403-9. PubMed ID: 7791114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aprindine on ischemia/reperfusion-induced cardiac contractile dysfunction of perfused rat heart.
    Kamiyama T; Tanonaka K; Hayashi J; Takeo S
    Jpn J Pharmacol; 1996 Mar; 70(3):227-34. PubMed ID: 8935716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propafenone and disopyramide enhance post-ischemic contractile and metabolic recovery of perfused hearts.
    Liu JX; Tanonaka K; Yamamoto K; Takeo S
    Eur J Pharmacol; 1993 Dec; 250(3):361-9. PubMed ID: 8112396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
    Tosaki A; Engelman DT; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TA-3090, a new calcium channel blocker, on myocardial substrate utilization in ischemic and nonischemic isolated working fatty acid-perfused rat hearts.
    Davies NJ; McVeigh JJ; Lopaschuk GD
    Circ Res; 1991 Mar; 68(3):807-17. PubMed ID: 1742868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart.
    Tanonaka K; Taguchi T; Koshimizu M; Ando T; Morinaka T; Yogo T; Konishi F; Takeo S
    J Pharmacol Exp Ther; 1999 Nov; 291(2):710-6. PubMed ID: 10525091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts.
    Akita T; Abe T; Kato S; Kodama I; Toyama J
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
    Grover GJ; Sleph PG; Dzwonczyk S; Malone HJ; Behling RW
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):28-38. PubMed ID: 9007667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart.
    Tanonaka K; Kamiyama T; Takezono A; Sakai K; Takeo S
    J Mol Cell Cardiol; 1996 Aug; 28(8):1659-70. PubMed ID: 8877776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N-(2-mercaptopropionyl)-glycine on mitochondrial function in ischemic-reperfused heart.
    Tanonaka K; Iwai T; Motegi K; Takeo S
    Cardiovasc Res; 2003 Feb; 57(2):416-25. PubMed ID: 12566114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of ischemia/reperfusion-induced contractile dysfunction of perfused hearts by class Ic antiarrhythmic agents.
    Liu JX; Tanonaka K; Ohtsuka Y; Sakai Y; Takeo S
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1247-54. PubMed ID: 8371134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of mitochondrial function may contribute to cardioprotective effects of Na+/Ca2+ exchanger inhibitors in ischaemic/reperfused rat hearts.
    Motegi K; Tanonaka K; Takenaga Y; Takagi N; Takeo S
    Br J Pharmacol; 2007 Aug; 151(7):963-78. PubMed ID: 17549042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
    Becker BF; Möbert J
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):287-94. PubMed ID: 10543430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.